• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
MDR

MEDADVISOR LIMITED - Announcements

2.22% ! 4.4¢
Market Cap $27.82M  !

MedAdvisor Limited is an Australia-based company engaged in offering pharmacy-driven... MedAdvisor Limited is an Australia-based company engaged in offering pharmacy-driven patient engagement solutions that provide personalized patient experiences to help simplify the patient medication journey. Leveraging THRiV, a cloud-based, artificial intelligence (AI)-enabled platform, the Company enables the pharmacy with an improved pharmacy workflow and patient engagement solutions. THRiV analyzes hundreds of data points, from prescription history to socioeconomic factors, to anticipate patient needs. This technology allows the Company to deliver personalized strategies tailored to each individual. Its integrated platform provides users to manage, distribute and access medication information, including product information (PIs), consumer medicine information (CMIs) or patient leaflets (PL), instructions for use (IFUs) leaflets or videos, in real time. The Company's subsidiaries include MedAdvisor Welam USA Inc. and Adheris, LLC.More

Announcements



Filters [Clear]
  • Price Sensitive: Yes
MDR Appendix 4E and Preliminary Financial Report-MDR.AX PRICE SENSITIVE26/08/16 download Created with Sketch. 264.88KB
MDR MedAdvisor launches new NDSS feature with Diabetes Aust-MDR.AX PRICE SENSITIVE25/08/16 download Created with Sketch. 96.67KB
MDR Glaucoma Australia Partnership to assist 300,000 Australians-MDR.AX PRICE SENSITIVE15/08/16 download Created with Sketch. 78.62KB
MDR Quarterly Activities Report and Appendix 4C - June 16-MDR.AX PRICE SENSITIVE29/07/16 download Created with Sketch. 137.72KB
MDR Major Biopharmaceutical Signs to Patient Engagement Program-MDR.AX PRICE SENSITIVE01/07/16 download Created with Sketch. 63.83KB
MDR Strong Growth in Key Business Drivers-MDR.AX PRICE SENSITIVE29/06/16 download Created with Sketch. 85.01KB
MDR GlaxoSmithKline Extends Service Agreement with MedAdvisor-MDR.AX PRICE SENSITIVE16/06/16 download Created with Sketch. 64.56KB
MDR Sales Channel Secured with Arrow Pharmaceuticals-MDR.AX PRICE SENSITIVE01/06/16 download Created with Sketch. 64.26KB
MDR Novartis Pharmaceuticals Australia to use MedAdvisor-MDR.AX PRICE SENSITIVE30/05/16 download Created with Sketch. 64.66KB
MDR MDR Quarterly Activities Report and Appendix 4C-MDR.AX PRICE SENSITIVE29/04/16 download Created with Sketch. 90.11KB
MDR MedAdvisor & Arrow to launch strategic partnershipPRICE SENSITIVE21/03/16 download Created with Sketch. 27.62KB
MDR MedAdvisor launches 1st phase of highly anticipated GP LinkPRICE SENSITIVE18/03/16 download Created with Sketch. 36.01KB
MDR Appendix 4D - MedAdvisor Half Year Financial Results Dec-15PRICE SENSITIVE29/02/16 download Created with Sketch. 454.94KB
MDR QUARTERLY ACTIVITIES REPORT and APPENDIX 4CPRICE SENSITIVE29/01/16 download Created with Sketch. 116.21KB
MDR MDR reaches 1 million prescription milestonePRICE SENSITIVE22/01/16 download Created with Sketch. 25.51KB
MDR Signs partnership agreement with Epilepsy Queensland Inc.PRICE SENSITIVE08/01/16 download Created with Sketch. 24.94KB
MDR Reinstatement to Official Quotation - 1 December 2015PRICE SENSITIVE30/11/15 download Created with Sketch. 251.26KB
MDR Appendix 4E and Preliminary Financial Report-MDR.AX
26/08/16PRICE SENSITIVE download Created with Sketch. 264.88KB
MDR MedAdvisor launches new NDSS feature with Diabetes Aust-MDR.AX
25/08/16PRICE SENSITIVE download Created with Sketch. 96.67KB
MDR Glaucoma Australia Partnership to assist 300,000 Australians-MDR.AX
15/08/16PRICE SENSITIVE download Created with Sketch. 78.62KB
MDR Quarterly Activities Report and Appendix 4C - June 16-MDR.AX
29/07/16PRICE SENSITIVE download Created with Sketch. 137.72KB
MDR Major Biopharmaceutical Signs to Patient Engagement Program-MDR.AX
01/07/16PRICE SENSITIVE download Created with Sketch. 63.83KB
MDR Strong Growth in Key Business Drivers-MDR.AX
29/06/16PRICE SENSITIVE download Created with Sketch. 85.01KB
MDR GlaxoSmithKline Extends Service Agreement with MedAdvisor-MDR.AX
16/06/16PRICE SENSITIVE download Created with Sketch. 64.56KB
MDR Sales Channel Secured with Arrow Pharmaceuticals-MDR.AX
01/06/16PRICE SENSITIVE download Created with Sketch. 64.26KB
MDR Novartis Pharmaceuticals Australia to use MedAdvisor-MDR.AX
30/05/16PRICE SENSITIVE download Created with Sketch. 64.66KB
MDR MDR Quarterly Activities Report and Appendix 4C-MDR.AX
29/04/16PRICE SENSITIVE download Created with Sketch. 90.11KB
MDR MedAdvisor & Arrow to launch strategic partnership
21/03/16PRICE SENSITIVE download Created with Sketch. 27.62KB
MDR MedAdvisor launches 1st phase of highly anticipated GP Link
18/03/16PRICE SENSITIVE download Created with Sketch. 36.01KB
MDR Appendix 4D - MedAdvisor Half Year Financial Results Dec-15
29/02/16PRICE SENSITIVE download Created with Sketch. 454.94KB
MDR QUARTERLY ACTIVITIES REPORT and APPENDIX 4C
29/01/16PRICE SENSITIVE download Created with Sketch. 116.21KB
MDR MDR reaches 1 million prescription milestone
22/01/16PRICE SENSITIVE download Created with Sketch. 25.51KB
MDR Signs partnership agreement with Epilepsy Queensland Inc.
08/01/16PRICE SENSITIVE download Created with Sketch. 24.94KB
MDR Reinstatement to Official Quotation - 1 December 2015
30/11/15PRICE SENSITIVE download Created with Sketch. 251.26KB
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
4.4¢
Change
-0.001(2.22%)
Mkt cap ! $27.82M
Open High Low Value Volume
4.4¢ 4.4¢ 4.3¢ $21.04K 485.8K

Buyers (Bids)

No. Vol. Price($)
1 10000 4.3¢
 

Sellers (Offers)

Price($) Vol. No.
4.6¢ 49980 1
View Market Depth
Last trade - 15.44pm 12/09/2025 (20 minute delay) ?
MDR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.